Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Alzheimer's Needs Cures, Not Pyrrhic Victories
Motley Fool
Mon, 07/21/14 - 09:17 am
Tags:
Alzheimer's disease, pimavanserin, Acadia, Sangamo BioSciences, Valeant Pharmaceuticals, Bexarotene, Merck, BACE inhibitors, AstraZeneca, solanezumab, Eli Lilly
Eli Lilly joins forces with UK biotech to develop cancer drugs
FT.com
Wed, 07/16/14 - 10:39 am
Tags:
Eli Lilly, UK, Immunocore, R&D, cancer
Lilly Offers ‘Misleading’ Facts in our Patent Dispute, Says Canada
WSJ Online
Tue, 07/15/14 - 11:49 am
Tags:
Eli Lilly, patents, Canada, Strattera, Zyprexa
Eli Lilly announces results from five datasets from Alzheimer's disease study
The Fly on the Wall
Tue, 07/15/14 - 09:46 am
Tags:
Eli Lilly, Alzheimer's disease
New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice
Yahoo/PR NewsWire
Sun, 07/13/14 - 11:16 am
Tags:
Alzheimer's disease, Eli Lilly
Sanofi sues Eli Lilly over insulin rival to Lantus
Yahoo/Reuters
Tue, 07/8/14 - 04:44 pm
Tags:
Sanofi, Eli Lilly, Lantus, diabetes, insulin
Testosterone elevating drugs free of heart attack risk, study says
Fierce Pharma
Mon, 07/7/14 - 07:31 pm
Tags:
testosterone, AbbVie, Androgel, heart attacks, Eli Lilly, Pfizer
Eli Lilly's anti-takeover superpower? A shield forged by Indiana lawmakers
Fierce Pharma
Fri, 06/27/14 - 09:55 am
Tags:
Eli Lilly, Indiana, M&A
Lilly Wins EU Backing for Generic of Sanofi’s Lantus
Bloomberg
Fri, 06/27/14 - 09:19 am
Tags:
Europe, generics, Eli Lilly, Sanofi, Lantus, diabetes
If You Thought Eli Lilly Could be Takeover Bait, Read This…
WSJ Online
Wed, 06/25/14 - 03:10 pm
Tags:
Eli Lilly, M&A
Eli Lilly: Climbing The Hill Of Survival And Success
Seeking Alpha
Wed, 06/25/14 - 07:39 am
Tags:
Eli Lilly
New rivals to top diabetes drug Lantus show promise in studies
Yahoo/Reuters
Sun, 06/15/14 - 10:33 am
Tags:
diabetes, Lantus, insulin, Sanofi, Toujeo, Eli Lilly
Should Pfizer Buy Eli Lilly?
Motley Fool
Fri, 06/13/14 - 06:52 pm
Tags:
Pfizer, Eli Lilly, M&A, AstraZeneca
Diabetes: The $54 billion battleground
CNBC
Fri, 06/13/14 - 12:26 pm
Tags:
diabetes, Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca
What Will Happen When Biotech Drugs Go Generic?
Forbes
Fri, 06/13/14 - 10:58 am
Tags:
biotech, generics, Amgen, Roche, Biogen Idec, Eli Lilly, Bristol-Myers Squibb, Sanofi, Novartis, Sandoz, Omnitrope, Genotropin
Lilly's Cyramza fails in liver cancer trial
Yahoo/Reuters
Wed, 06/11/14 - 10:20 am
Tags:
Eli Lilly, Cyramza, liver cancer
Lilly's head-to-head with Victoza raises a red flag for diabetes drug dulaglutide
Fierce Biotech
Mon, 06/9/14 - 01:21 pm
Tags:
Victoza, Eli Lilly, diabetes, dulaglutide
FirstWord List: Top 15 pharma and lead product dependency
First Word Pharma
Mon, 06/9/14 - 10:35 am
Tags:
Teva, AbbVie, Boehringer Ingelheim, GSK, Sanofi, Amgen, Eli Lilly, JNJ, AstraZeneca, Roche, Novartis, Merck, Pfizer, Takeda, Bristol-Myers Squibb
ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?
Yahoo/Benzinga
Thu, 06/5/14 - 09:14 am
Tags:
ASCO, Pfizer, Aromasin, tamoxifen, DARA Biosciences, breast cancer, Herceptin, Tykerb, GSK, Eli Lilly, Bristol-Myers Squibb, Erbitux
ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy
Yahoo/Benzinga
Wed, 06/4/14 - 03:20 pm
Tags:
ASCO, cancer, Imbruvica, JNJ, Eli Lilly, Cyramza

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.